Innate Pharma SA Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement
Innate Pharma SA (IPHYF) had Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement of 481044800.00% as of 2019-12-31, per its 20-F filed 2020-04-24.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement · last filed 2020-04-24
- 2019-12-31: Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement 481044800.00%.
- 2018-12-31: Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement 486210000.00%.
| Period end | Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement |
|---|---|
| 2019-12-31 | 481044800.00% 20-F · filed 2020-04-24 |
| 2018-12-31 | 486210000.00% 20-F · filed 2020-04-24 |